Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Primorus Adds Three Directors To Board

Wed, 23rd Sep 2020 19:22

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News:

----------

Primorus Investments PLC - investment firm focussed on natural resources sector - Appoints Rupert Labrum, Hedley Clark and Matthew Beardmore as directors, subject to due diligence checks, following request from unnamed investor who initially sought to requisition general meeting. Donald Strang to step down when new additions join board but Executive Chair Jeremy Taylor-Firth and Executive Director Alastair Clayton to remain. Primorus notes that notice to requisition general meeting has been withdrawn.

----------

Templeton Emerging Markets IT PLC - emerging markets investor - Adds Medha Samant to board as non-executive director from October 1. Spent about 10 years as investment director for Asian equities at Fidelity International.

----------

Asimilar Group PLC - technology-focused investor - Mark Horrocks joins immediately as non-executive director. "He has worked as a research analyst and fund manager for a FTSE100 insurance group," Asimilar notes. Donald Stewart to step down from board at the conclusion of company annual general meeting.

----------

BB Healthcare Trust PLC - healthcare-focused investor - Appoints Toby Young as non-executive director immediately. "Professor Young is a practicing frontline NHS consultant urological surgeon, director of medical Innovation at Anglia Ruskin University, president of the Institute of Decontamination Sciences, and national clinical director for Innovation for the NHS," BB Healthcare said.

----------

4d Pharma PLC - drug developer - Adds Katrin Rupalla to board as non-executive director with immediate effect. Chief Executive Officer Duncan Peyton said: "We are delighted to be able to attract someone of Katrin's calibre to our board of directors. Her vast experience guiding novel therapies through the clinic will be invaluable as we progress our pipeline of novel live biotherapeutics into and through the clinic."

----------

Hurricane Energy PLC - Goldaming, England-based oil exploration company - Non-executive Director Alan Parsley retired with effect Wednesday. Leonard Tao also steps down as alternate.

----------

Base Resources Ltd - Australia-based mineral sands producer and developer - Appoints Janine Herzig to board as non-executive director from October 12. "Ms Herzig has 30 years' experience in the resources sector, encompassing executive management, consulting, technical and production roles, across all commodities including industrial minerals," Base said. Sam Willis to step down as a non-executive director from November 20.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 Feb 2015 16:06

UK AGM, EGM Calendar - Week Ahead

Read more
21 Jan 2015 08:51

4D Pharma Raises GBP34.8 Million Through Share Placing (ALLISS)

Read more
23 Sep 2014 12:24

4d Pharma Posts First-Half Loss, Says Pipeline Is Strong

Read more
2 Sep 2014 10:21

4D pharma progresses with IBS and Crohn's treatments

4D pharma has announced that its treatments for Irritable Bowel Syndrome (IBS) and Paediatric Crohn's Disease (PCD) are expected to enter clinical studies in the second quarter of 2015. The studies, which will be focused on evaluating safety and tolerability of the products as well as some clinica

Read more
2 Sep 2014 07:26

UK MORNING BRIEFING: Weir Group Leads Firm London Market On Upgrade

Read more
2 Sep 2014 06:55

4d Pharma's Blautix, Thetanix To Start Clinical Studies In 2015

Read more
7 Aug 2014 08:28

4d Pharma Gets Orphan Drug Designation From US FDA

Read more
7 Aug 2014 07:32

UK MORNING BRIEFING: Old Mutual, Coca-Cola HBC And RSA Weigh On FTSE

Read more
18 Jul 2014 10:00

4d Pharma Buys Microbiota For GBP2.0 Million

Read more
18 Jul 2014 07:25

UK MORNING BRIEFING: Shares Lower On Ukraine Crash, Gaza Offensive

Read more
25 Jun 2014 10:11

4d Pharma Raises GBP21.5 Million In Share Placing

Read more
25 Jun 2014 07:40

UK MORNING BRIEFING: Shares Down; Land Securities Buys Into Bluewater

Read more
4 Jun 2014 10:17

4d Pharma Raises Stake In GT Biologics To 83.5%

LONDON (Alliance News) - 4d Pharma PLC Wednesday said it has acquired a further 37.5% stake in GT Biologics Ltd for GBP1.22 million in new 4d Pharma shares, taking its total shareholding in the GT Biologics to 83.5%. 4d Pharma, which focuses on significant new therapeutic areas, said the ac

Read more
4 Jun 2014 07:53

4d pharma increases stake in GT Biologics to nearly 84%

4d pharma, an AIM-listed pharmaceutical company focused on new therapeutic areas, has added an additional 37.5% to its stake in GT Biologics taking its current holding to around 83.5%. The £1.22m consideration was satisfied by the issue of 699,500 new 4d shares at 175p each, reflecting their avera

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.